NASH Market Overview 2019

A followup to our NASH Market Research from 2018.

Research Objectives:

  • Understand the current Nonalcoholic steatohepatitis (NASH) treatment landscape and areas of unmet need

  • Explore what physicians know about the current state of affairs in the NASH market and pipeline and what physicians anticipate for the future of NASH treatment

Method: 10-minute MicroSurvey via InCrowd
Crowds: US Gastroenterologists, US Hepatologists
Sample Size: n=54
Fielding Period: March 6-7, 2019

One key finding:

  • Physicians treat over 30 NASH patients in a typical month and are generally aware of treatments in development for NASH.
    • They are diagnosing these patients using mostly blood tests and ultrasounds and sometimes use transient elastography, liver biopsy, and CT scan

Download the full report now!

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Five Ways to Improve MedTech DTC Patient Engagement

Five Ways to Improve MedTech DTC Patient Engagement

US Patient & Physician Perspectives For this year's DTC National Conference, InCrowd wanted to demonstrate the ways in which diabetic patients perceive DTC ads for medical devices designed to help treat their condition. We also examined how treating...

read more
Pre-ASCO Excitement Report

Pre-ASCO Excitement Report

Instant Insights It’s just 3 weeks until ASCO (American Society of Clinical Oncology’s annual meeting), and oncologists have shared with us the agenda topics that most interest them. Immunotherapies topped the list, with CAR-T the most popular among them. Take a look...

read more